+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
De-Identified Health Data Market Size, Share & Trends Analysis Report by Type of Data, Application, End-Use (Pharmaceutical Companies, Biotechnology Firms, Medical Device Manufacturers, Healthcare Providers), and Region with Growth Forecasts, 2025-2030- Product Image
De-Identified Health Data Market Size, Share & Trends Analysis Report by Type of Data, Application, End-Use (Pharmaceutical Companies, Biotechnology Firms, Medical Device Manufacturers, Healthcare Providers), and Region with Growth Forecasts, 2025-2030- Product Image
New

De-Identified Health Data Market Size, Share & Trends Analysis Report by Type of Data, Application, End-Use (Pharmaceutical Companies, Biotechnology Firms, Medical Device Manufacturers, Healthcare Providers), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 6024607
Description Jump to:
The De-Identified Health Data Market was valued at USD 8.09 billion in 2024, and is projected to reach USD 13.59 billion by 2030, rising at a CAGR of 9.07%. The market's growth is primarily driven by the rising demand for data analytics in healthcare, which supports population health studies and predictive modeling while ensuring patient privacy. Increasing regulatory pressure surrounding data protection, combined with AI and machine learning advancements, is creating a growing need for large-scale, de-identified datasets. In addition, the surge in data from wearables and electronic health records (EHRs) generates substantial volumes of information suitable for de-identification and secondary use, further boosting market demand.

De-identified data is utilized to derive insights into insurance status by analyzing patterns related to patient enrollment in pharmacy and medical insurance. This data enables organizations to identify primary and secondary payers, assess coverage trends, and understand patient demographics without compromising privacy. For instance, in June 2024, Komodo Health introduced the Komodo Patient Insurance (KPI). This novel data offering provides detailed insights into the insurance status of over 200 million de-identified U.S. patients. This resource accurately identifies patients' pharmacy and medical insurance enrollment, detailing primary and secondary payer information across various channels, segments, and geographies. The KPI will assist Commercial, Market Access, Medical Affairs, and Health Economics and Outcomes Research (HEOR) teams in efficiently addressing key business questions related to patient enrollment and payer mapping.

Moreover, the increasing partnership and collaboration among the key market players are expected to drive market growth. For instance, in March 2024, Verantos announced a partnership with Curimeta to enhance the utilization of de-identified health data in clinical research. This collaboration focuses on improving real-world evidence generation while ensuring patient privacy through robust data de-identification processes. By leveraging Curimeta’s data science capabilities and Verantos’ expertise in real-world data, the partnership aims to provide valuable insights that can drive healthcare innovations and improve patient outcomes. The emphasis on de-identified data is crucial for facilitating secure data sharing and compliance with regulatory standards.

“The Verantos Evidence Platform uses artificial intelligence (AI) to generate unique disease-specific insights. It is critical that AI models are trained using high-quality patient care data. CuriMeta’s participation will enable us to enhance our disease-specific Pragmatic Registries that are used to accelerate life sciences research.”
  • Anand Shroff, President of Verantos

De-identified Health Data Market Report Highlights

  • Based on the type of data, the clinical data segment dominated the market with almost 17.0% of the share in 2024. The segment's dominance is attributed to its crucial role in research, treatment development, and patient care optimization.
  • Based on application, the clinical research and trials segment held the largest revenue share in 2024. This is attributed to its key role in advancing treatment methods, medical device innovation, and patient safety.
  • Based on the end-use, the healthcare providers segment held the largest revenue share in 2024. The healthcare providers segment leads the market owing to its crucial role in clinical decision-making, treatment optimization, and patient outcome improvement.
  • North America dominated the market with a revenue share of 31.53% in 2024. The region has an advanced healthcare infrastructure and significant technological investment, particularly in data analytics and AI.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type of data
1.1.2. End use
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type of data outlook
2.2.2. End use outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. De-identified Health Data Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market Opportunity analysis
3.3. De-identified Health Data Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.3.3. COVID-19 Impact
Chapter 4. De-identified Health Data Market: Type of Data Estimates & Trend Analysis
4.1. Type of Data Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global De-identified Health Data Market by Type of Data Outlook
4.4. Clinical Data
4.4.1. Market estimates and forecast 2018-2030 (USD Million)
4.5. Genomic Data
4.5.1. Market estimates and forecast 2018-2030 (USD Million)
4.6. Patient Demographics
4.6.1. Market estimates and forecast 2018-2030 (USD Million)
4.7. Prescription Data
4.7.1. Market estimates and forecast 2018-2030 (USD Million)
4.8. Claims Data
4.8.1. Market estimates and forecast 2018-2030 (USD Million)
4.9. Behavioral Data
4.9.1. Market estimates and forecast 2018-2030 (USD Million)
4.10. Wearable and Sensor Data
4.10.1. Market estimates and forecast 2018-2030 (USD Million)
4.11. Survey and Patient-Reported Data
4.11.1. Market estimates and forecast 2018-2030 (USD Million)
4.12. Imaging Data
4.12.1. Market estimates and forecast 2018-2030 (USD Million)
4.13. Laboratory Data
4.13.1. Market estimates and forecast 2018-2030 (USD Million)
4.14. Hospital and Provider Data
4.14.1. Market estimates and forecast 2018-2030 (USD Million)
4.15. Social Determinants of Health (SDoH) Data
4.15.1. Market estimates and forecast 2018-2030 (USD Million)
4.16. Pharmacogenomic Data
4.16.1. Market estimates and forecast 2018-2030 (USD Million)
4.17. Biometric Data
4.17.1. Market estimates and forecast 2018-2030 (USD Million)
4.18. Operational and Financial Data
4.18.1. Market estimates and forecast 2018-2030 (USD Million)
4.19. Epidemiological Data
4.19.1. Market estimates and forecast 2018-2030 (USD Million)
4.20. Healthcare Utilization Data
4.20.1. Market estimates and forecast 2018-2030 (USD Million)
4.21. Others
4.21.1. Market estimates and forecast 2018-2030 (USD Million)
Chapter 5. De-identified Health Data Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global De-identified Health Data Market by End Use Outlook
5.4. Pharmaceutical Companies
5.4.1. Market estimates and forecast 2018-2030 (USD Million)
5.5. Biotechnology Firms
5.5.1. Market estimates and forecast 2018-2030 (USD Million)
5.6. Medical Device Manufacturers
5.6.1. Market estimates and forecast 2018-2030 (USD Million)
5.7. Healthcare Providers
5.7.1. Market estimates and forecast 2018-2030 (USD Million)
5.8. Insurance Companies/ Healthcare Payers
5.8.1. Market estimates and forecast 2018-2030 (USD Million)
5.9. Research Institutions
5.9.1. Market estimates and forecast 2018-2030 (USD Million)
5.10. Government Agencies
5.10.1. Market estimates and forecast 2018-2030 (USD Million)
5.11. Others
5.11.1. Market estimates and forecast 2018-2030 (USD Million)
Chapter 6. De-identified Health Data Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global De-identified Health Data Market by Application Outlook
6.4. Clinical Research and Trials
6.4.1. Market estimates and forecast 2018-2030 (USD Million)
6.5. Public Health
6.5.1. Market estimates and forecast 2018-2030 (USD Million)
6.6. Precision Medicine
6.6.1. Market estimates and forecast 2018-2030 (USD Million)
6.7. Health Economics and Outcomes Research (HEOR)
6.7.1. Market estimates and forecast 2018-2030 (USD Million)
6.8. Population Health Management
6.8.1. Market estimates and forecast 2018-2030 (USD Million)
6.9. Drug Discovery and Development
6.9.1. Market estimates and forecast 2018-2030 (USD Million)
6.10. Healthcare Quality Improvement
6.10.1. Market estimates and forecast 2018-2030 (USD Million)
6.11. Insurance Underwriting and Risk Assessment
6.11.1. Market estimates and forecast 2018-2030 (USD Million)
6.12. Market Access and Commercial Strategy
6.12.1. Market estimates and forecast 2018-2030 (USD Million)
6.13. Business Intelligence and Operational Efficiency
6.13.1. Market estimates and forecast 2018-2030 (USD Million)
6.14. Telemedicine and Remote Monitoring
6.14.1. Market estimates and forecast 2018-2030 (USD Million)
6.15. Patient Engagement and Support Programs
6.15.1. Market estimates and forecast 2018-2030 (USD Million)
6.16. Others
6.16.1. Market estimates and forecast 2018-2030 (USD Million)
Chapter 7. De-identified Health Data Market: Regional Estimates & Trend Analysis, by Type of Data, by End use, by Application
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size & Forecasts Trend Analysis, 2018-2030
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018-2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. Mexico market estimates and forecasts 2018-2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018-2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018-2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018-2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018-2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018-2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018-2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018-2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018-2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018-2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018-2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018-2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018-2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018-2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Singapore market estimates and forecasts 2018-2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018-2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Argentina market estimates and forecasts 2018-2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018-2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018-2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018-2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Innovators
8.4. Vendor Landscape
8.4.1. List of key distributors and channel partners
8.4.2. Key customers
8.4.3. Key company market share analysis, 2024
8.4.4. IQVIA
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Technology Type benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Oracle (Cerner Corporation)
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Technology Type benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Merative (Truven Health Analytics)
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Technology Type benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Optum, Inc. (UnitedHealth Group)
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Technology Type benchmarking
8.4.7.4. Strategic initiatives
8.4.8. ICON plc
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Technology Type benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Veradigm LLC (Formerly known as Allscripts)
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Technology Type benchmarking
8.4.9.4. Strategic initiatives
8.4.10. IBM
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Technology Type benchmarking
8.4.10.4. Strategic initiatives
8.4.11. Flatiron Health (F. Hoffmann-La Roche Ltd)
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Technology Type benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Premier, Inc.
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Technology Type benchmarking
8.4.12.4. Strategic initiatives
8.4.13. Shaip
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Technology Type benchmarking
8.4.13.4. Strategic initiatives
8.4.14. Komodo Health, Inc.
8.4.14.1. Company overview
8.4.14.2. Financial performance
8.4.14.3. Technology Type benchmarking
8.4.14.4. Strategic initiatives
8.4.15. Evidation Health, Inc.
8.4.15.1. Company overview
8.4.15.2. Financial performance
8.4.15.3. Technology Type benchmarking
8.4.15.4. Strategic initiatives
8.4.16. Medidata
8.4.16.1. Company overview
8.4.16.2. Financial performance
8.4.16.3. Technology Type benchmarking
8.4.16.4. Strategic initiatives
8.4.17. Clarify Health Solutions
8.4.17.1. Company overview
8.4.17.2. Financial performance
8.4.17.3. Technology Type benchmarking
8.4.17.4. Strategic initiatives
8.4.18. Satori Cyber Ltd.
8.4.18.1. Company overview
8.4.18.2. Financial performance
8.4.18.3. Technology Type benchmarking
8.4.18.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America de-identified health data market, by region, 2018-2030 (USD Million)
Table 3 North America de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 4 North America de-identified health data market, by end use, 2018-2030 (USD Million)
Table 5 North America de-identified health data market, by application, 2018-2030 (USD Million)
Table 6 U.S. de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 7 U.S. de-identified health data market, by end use, 2018-2030 (USD Million)
Table 8 U.S. de-identified health data market, by application, 2018-2030 (USD Million)
Table 9 Canada de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 10 Canada de-identified health data market, by end use, 2018-2030 (USD Million)
Table 11 Canada de-identified health data market, by application, 2018-2030 (USD Million)
Table 12 Mexico de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 13 Mexico de-identified health data market, by end use, 2018-2030 (USD Million)
Table 14 Mexico de-identified health data market, by application, 2018-2030 (USD Million)
Table 15 Europe de-identified health data market, by region, 2018-2030 (USD Million)
Table 16 Europe de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 17 Europe de-identified health data market, by end use, 2018-2030 (USD Million)
Table 18 Europe de-identified health data market, by application, 2018-2030 (USD Million)
Table 19 Germany de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 20 Germany de-identified health data market, by end use, 2018-2030 (USD Million)
Table 21 Germany de-identified health data market, by application, 2018-2030 (USD Million)
Table 22 UK de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 23 UK de-identified health data market, by end use, 2018-2030 (USD Million)
Table 24 UK de-identified health data market, by application, 2018-2030 (USD Million)
Table 25 France de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 26 France de-identified health data market, by end use, 2018-2030 (USD Million)
Table 27 France de-identified health data market, by application, 2018-2030 (USD Million)
Table 28 Italy de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 29 Italy de-identified health data market, by end use, 2018-2030 (USD Million)
Table 30 Italy de-identified health data market, by application, 2018-2030 (USD Million)
Table 31 Spain de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 32 Spain de-identified health data market, by end use, 2018-2030 (USD Million)
Table 33 Spain de-identified health data market, by application, 2018-2030 (USD Million)
Table 34 Denmark de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 35 Denmark de-identified health data market, by end use, 2018-2030 (USD Million)
Table 36 Denmark de-identified health data market, by application, 2018-2030 (USD Million)
Table 37 Sweden de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 38 Sweden de-identified health data market, by end use, 2018-2030 (USD Million)
Table 39 Sweden de-identified health data market, by application, 2018-2030 (USD Million)
Table 40 Norway de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 41 Norway de-identified health data market, by end use, 2018-2030 (USD Million)
Table 42 Norway de-identified health data market, by application, 2018-2030 (USD Million)
Table 43 Asia Pacific de-identified health data market, by region, 2018-2030 (USD Million)
Table 44 Asia Pacific de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 45 Asia Pacific de-identified health data market, by end use, 2018-2030 (USD Million)
Table 46 Asia Pacific de-identified health data market, by application, 2018-2030 (USD Million)
Table 47 China de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 48 China de-identified health data market, by end use, 2018-2030 (USD Million)
Table 49 China de-identified health data market, by application, 2018-2030 (USD Million)
Table 50 Japan de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 51 Japan de-identified health data market, by end use, 2018-2030 (USD Million)
Table 52 Japan de-identified health data market, by application, 2018-2030 (USD Million)
Table 53 India de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 54 India de-identified health data market, by end use, 2018-2030 (USD Million)
Table 55 India de-identified health data market, by application, 2018-2030 (USD Million)
Table 56 South Korea de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 57 South Korea de-identified health data market, by end use, 2018-2030 (USD Million)
Table 58 South Korea de-identified health data market, by application, 2018-2030 (USD Million)
Table 59 Australia de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 60 Australia de-identified health data market, by end use, 2018-2030 (USD Million)
Table 61 Australia de-identified health data market, by application, 2018-2030 (USD Million)
Table 62 Thailand de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 63 Thailand de-identified health data market, by end use, 2018-2030 (USD Million)
Table 64 Thailand de-identified health data market, by application, 2018-2030 (USD Million)
Table 65 Latin America de-identified health data market, by region, 2018-2030 (USD Million)
Table 66 Latin America de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 67 Latin America de-identified health data market, by end use, 2018-2030 (USD Million)
Table 68 Latin America de-identified health data market, by application, 2018-2030 (USD Million)
Table 69 Brazil de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 70 Brazil de-identified health data market, by end use, 2018-2030 (USD Million)
Table 71 Brazil de-identified health data market, by application, 2018-2030 (USD Million)
Table 72 Argentina de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 73 Argentina de-identified health data market, by end use, 2018-2030 (USD Million)
Table 74 Argentina de-identified health data market, by application, 2018-2030 (USD Million)
Table 75 MEA de-identified health data market, by region, 2018-2030 (USD Million)
Table 76 MEA de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 77 MEA de-identified health data market, by end use, 2018-2030 (USD Million)
Table 78 MEA de-identified health data market, by application, 2018-2030 (USD Million)
Table 79 South Africa de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 80 South Africa de-identified health data market, by end use, 2018-2030 (USD Million)
Table 81 South Africa de-identified health data market, by application, 2018-2030 (USD Million)
Table 82 Saudi Arabia de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 83 Saudi Arabia de-identified health data market, by end use, 2018-2030 (USD Million)
Table 84 Saudi Arabia de-identified health data market, by application, 2018-2030 (USD Million)
Table 85 UAE de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 86 UAE de-identified health data market, by end use, 2018-2030 (USD Million)
Table 87 UAE de-identified health data market, by application, 2018-2030 (USD Million)
Table 88 Kuwait de-identified health data market, by type of data, 2018-2030 (USD Million)
Table 89 Kuwait de-identified health data market, by end use, 2018-2030 (USD Million)
Table 90 Kuwait de-identified health data market, by application, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 De-identified Health Data market: market outlook
Figure 9 De-identified Health Data competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 De-identified Health Data market driver impact
Figure 15 De-identified Health Data market restraint impact
Figure 16 De-identified Health Data market strategic initiatives analysis
Figure 17 De-identified Health Data market: Type of Data movement analysis
Figure 18 De-identified Health Data market: Type of Data outlook and key takeaways
Figure 19 Clinical data market estimates and forecast, 2018-2030
Figure 20 Genomic data market estimates and forecast, 2018-2030
Figure 21 Patient demographics market estimates and forecast, 2018-2030
Figure 22 Prescription data market estimates and forecast, 2018-2030
Figure 23 Claims data market estimates and forecast, 2018-2030
Figure 24 Behavioral data market estimates and forecast, 2018-2030
Figure 25 Wearable and sensor data market estimates and forecast, 2018-2030
Figure 26 Survey and patient-reported data market estimates and forecast, 2018-2030
Figure 27 Imaging data market estimates and forecast, 2018-2030
Figure 28 Laboratory data market estimates and forecast, 2018-2030
Figure 29 Hospital and provider data market estimates and forecast, 2018-2030
Figure 30 Social determinants of health (SDoH) data market estimates and forecast, 2018-2030
Figure 31 Pharmacogenomic data market estimates and forecast, 2018-2030
Figure 32 Biometric data market estimates and forecast, 2018-2030
Figure 33 Operational and financial data market estimates and forecast, 2018-2030
Figure 34 Epidemiological data market estimates and forecast, 2018-2030
Figure 35 Healthcare utilization data market estimates and forecast, 2018-2030
Figure 36 Others market estimates and forecast, 2018-2030
Figure 37 De-identified Health Data market: End use analysis
Figure 38 De-identified Health Data market: End use outlook and key takeaways
Figure 39 Pharmaceutical companies market estimates and forecast, 2018-2030
Figure 40 Biotechnology firms market estimates and forecast, 2018-2030
Figure 41 Medical device manufacturers market estimates and forecast, 2018-2030
Figure 42 Healthcare providers market estimates and forecast, 2018-2030
Figure 43 Insurance companies/ Healthcare payers market estimates and forecast, 2018-2030
Figure 44 Research institutions market estimates and forecast, 2018-2030
Figure 45 Government agencies market estimates and forecast, 2018-2030
Figure 46 Others market estimates and forecast, 2018-2030
Figure 47 De-identified Health Data market: Application movement analysis
Figure 48 De-identified Health Data market: Application outlook and key takeaways
Figure 49 Clinical research and trials market estimates and forecast, 2018-2030
Figure 50 Public health market estimates and forecast, 2018-2030
Figure 51 Precision medicine market estimates and forecast, 2018-2030
Figure 52 Health economics and outcomes research (HEOR) market estimates and forecast, 2018-2030
Figure 53 Population health management market estimates and forecast, 2018-2030
Figure 54 Drug discovery and development market estimates and forecast, 2018-2030
Figure 55 Healthcare quality improvement market estimates and forecast, 2018-2030
Figure 56 Insurance underwriting and risk assessment market estimates and forecast, 2018-2030
Figure 57 Market access and commercial strategy market estimates and forecast, 2018-2030
Figure 58 Business intelligence and operational efficiency market estimates and forecast, 2018-2030
Figure 59 Telemedicine and remote monitoring market estimates and forecast, 2018-2030
Figure 60 Patient engagement and support programs market estimates and forecast, 2018-2030
Figure 61 Others market estimates and forecast, 2018-2030
Figure 62 Global de-identified health data market: Regional movement analysis
Figure 63 Global de-identified health data market: Regional outlook and key takeaways
Figure 64 Global de-identified health data market share and leading players
Figure 65 North America market share and leading players
Figure 66 Europe market share and leading players
Figure 67 Asia Pacific market share and leading players
Figure 68 Latin America market share and leading players
Figure 69 Middle East & Africa market share and leading players
Figure 70 North America: SWOT
Figure 71 Europe SWOT
Figure 72 Asia Pacific SWOT
Figure 73 Latin America SWOT
Figure 74 MEA SWOT
Figure 75 North America, by country
Figure 76 North America
Figure 77 North America market estimates and forecasts, 2018-2030
Figure 78 U.S. key country dynamics
Figure 79 U.S. market estimates and forecasts, 2018-2030
Figure 80 Canada key country dynamics
Figure 81 Canada market estimates and forecasts, 2018-2030
Figure 82 Mexico key country dynamics
Figure 83 Mexico market estimates and forecasts, 2018-2030
Figure 84 Europe
Figure 85 Europe market estimates and forecasts, 2018-2030
Figure 86 UK key country dynamics
Figure 87 UK market estimates and forecasts, 2018-2030
Figure 88 Germany key country dynamics
Figure 89 Germany market estimates and forecasts, 2018-2030
Figure 90 France key country dynamics
Figure 91 France market estimates and forecasts, 2018-2030
Figure 92 Italy key country dynamics
Figure 93 Italy market estimates and forecasts, 2018-2030
Figure 94 Spain key country dynamics
Figure 95 Spain market estimates and forecasts, 2018-2030
Figure 96 Denmark key country dynamics
Figure 97 Denmark market estimates and forecasts, 2018-2030
Figure 98 Sweden key country dynamics
Figure 99 Sweden market estimates and forecasts, 2018-2030
Figure 100 Norway key country dynamics
Figure 101 Norway market estimates and forecasts, 2018-2030
Figure 102 Asia Pacific
Figure 103 Asia Pacific market estimates and forecasts, 2018-2030
Figure 104 China key country dynamics
Figure 105 China market estimates and forecasts, 2018-2030
Figure 106 Japan key country dynamics
Figure 107 Japan market estimates and forecasts, 2018-2030
Figure 108 India key country dynamics
Figure 109 India market estimates and forecasts, 2018-2030
Figure 110 Thailand key country dynamics
Figure 111 Thailand market estimates and forecasts, 2018-2030
Figure 112 South Korea key country dynamics
Figure 113 South Korea market estimates and forecasts, 2018-2030
Figure 114 Australia key country dynamics
Figure 115 Australia market estimates and forecasts, 2018-2030
Figure 116 Latin America
Figure 117 Latin America market estimates and forecasts, 2018-2030
Figure 118 Brazil key country dynamics
Figure 119 Brazil market estimates and forecasts, 2018-2030
Figure 120 Argentina key country dynamics
Figure 121 Argentina market estimates and forecasts, 2018-2030
Figure 122 Middle East and Africa
Figure 123 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 124 South Africa key country dynamics
Figure 125 South Africa market estimates and forecasts, 2018-2030
Figure 126 Saudi Arabia key country dynamics
Figure 127 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 128 UAE key country dynamics
Figure 129 UAE market estimates and forecasts, 2018-2030
Figure 130 Kuwait key country dynamics
Figure 131 Kuwait market estimates and forecasts, 2018-2030
Figure 132 Market share of key market players- de-identified health data market

Companies Mentioned

The major companies profiled in this De-Identified Health Data market report include:
  • IQVIA
  • Oracle (Cerner Corporation)
  • Merative (Truven Health Analytics)
  • Optum, Inc. (UnitedHealth Group)"
  • ICON plc
  • Veradigm LLC (Formerly known as Allscripts)
  • IBM
  • Flatiron Health (F. Hoffmann-La Roche Ltd)
  • Premier, Inc.
  • Shaip
  • Komodo Health, Inc.
  • Evidation Health, Inc.
  • Medidata
  • Clarify Health Solutions
  • Satori Cyber Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.09 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.59 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Patient Generated Health Data Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Patient Generated Health Data Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Healthcare Data Analytics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Healthcare Data Analytics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 104 Pages
  • Global
From
Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application (Population Health Management, Chronic Disease Management), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application (Population Health Management, Chronic Disease Management), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Healthcare Predictive Analytics Market Size, Share & Trends Analysis Report by Application (Clinical, Financial, Operations Management), End-use (Payers, Providers), Region, and Segment Forecasts, 2024-2030 - Product Image

Healthcare Predictive Analytics Market Size, Share & Trends Analysis Report by Application (Clinical, Financial, Operations Management), End-use (Payers, Providers), Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Clinical Risk Grouping Solution Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032 - Product Image

Clinical Risk Grouping Solution Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032

  • Report
  • 171 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.